Government urged to reconsider drug price cut

Published: 2011-07-25 06:59:00

Updated: 2011-07-25 06:59:00

To further stimulate research and development (R&D) in the pharmaceutical industry, the government should enhance certainty in pricing and reimbursement and adequately reward the developers of drugs with proven clinical benefits, the Korean Research based Pharmaceutical Industry Association (KRPIA) said Thursday.

In recent years, uncertainty has tended to increase in Korea’s pharmaceutical i...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.